1995
DOI: 10.1111/j.1527-3458.1995.tb00285.x
|View full text |Cite
|
Sign up to set email alerts
|

Glycine Site Agonists of the NMDA Receptor: A Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
31
1

Year Published

1997
1997
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(34 citation statements)
references
References 159 publications
2
31
1
Order By: Relevance
“…In recent clinical studies, administration of 30-60 g/day (0.4-0.8 g/kg/day) of glycine was found to induce significant amelioration of negative and cognitive symptoms (reviewed in Heresco-Levy et al 1996). These doses are known to significantly elevate CNS glycine levels (D'Souza et al 1995). Similar results have been obtained with the partial glycine agonist D -cycloserine (Goff et al 1995).…”
supporting
confidence: 73%
“…In recent clinical studies, administration of 30-60 g/day (0.4-0.8 g/kg/day) of glycine was found to induce significant amelioration of negative and cognitive symptoms (reviewed in Heresco-Levy et al 1996). These doses are known to significantly elevate CNS glycine levels (D'Souza et al 1995). Similar results have been obtained with the partial glycine agonist D -cycloserine (Goff et al 1995).…”
supporting
confidence: 73%
“…In addition, investigators have described postmortem evidence of changes in glutamate metabolism and AMPA, kainate, and NMDA receptor expression (Ulas and Cotman., 1997;D'Souza et al, 1995;Akbarian et al, 1996;Gao et al, 2000;Ibrahim et al, 2000;Meador-Woodruff and Healey, 2000;Humphries et al, 1996;Sokolov, 1998) in patients with schizophrenia. These findings and others may be consistent with decreases in optimal NMDA receptor function and/or a disturbance in related circuitry.…”
Section: Evidence For Nmda Receptor Hypofunction In Schizophreniamentioning
confidence: 98%
“…While D-serine and D-cycloserine have high affinity and selectivity for glycine sites of NMDA receptors, glycine is known to have high affinity for inhibitory glycine A receptors, which are distributed primarily in spinal cord and pons (Lynch 2004). Under moderate doses, glycine shows low blood-brain barrier (BBB) permeability (Oldendorph 1971;Toth and Lajtha 1986;D'Souza et al 1995). Furthermore, several studies of both rats and subjects with schizophrenia have suggested that the administration of glycine led to increases in the concentration of D-serine in the central nervous system (CNS) (Takahashi et al 1997;Heresco-Levy et al 2004a).…”
Section: Introductionmentioning
confidence: 99%